DeutschNewstral
Article
Forbes on 2015-07-22 13:00
Promising Alzheimer's Drugs Disappoint With Incremental Data
Related news
Promising Alzheimer's drug fails trialCNN- BEli Lilly Stock Falls as Sales Disappoint. Analyst Welcomes Diabetes Data.barrons.com
- BBiogen Stock Drops as Results Fall Short. Sales of Alzheimer's Drug Disappoint.3 min readbarrons.com
- BEli Lilly Stock Falls After Alzheimer's Drug Results Disappoint Wall Streetbarrons.com
- Economic Data Doesn’t Disappoint While The Market DoesForbes
- HEuropean Shares Mixed as German Factory Data Disappointhamodia.com
- MWill Medicare cover Eisai and Biogen's promising new Alzheimer's therapy if it's approved?3 min readmarketwatch.com
Global experts study promising drugs, vaccines for new virusstaradvertiser.com- Early Results On Alzheimer's Vaccine Trial In People With Down Syndrome Promising, Researchers SayForbes
One of the most promising drugs for Alzheimer's disease fails in clinical trialsLA Times- BBluebird Bio Gains on Promising Cancer-Drug Databarrons.com
Stock market today: Asia markets mixed ahead of Fed decision; China economic data disappointSeattle Times
D.C. pharmacist provides Alzheimer's drugs for members of Congress, he saysmetro.us
Opinion: New drugs could help Alzheimer's patients live longer. Is the health care system ready?sandiegouniontribune.com- BLilly and Biogen Want Full Medicare Coverage of Alzheimer's Drugs. It's Not Happening.5 min readbarrons.com
Global experts study promising drugs, vaccines for new virus - Tue, 11 Feb 2020 PSTThe Spokesman-Review